Dihydrolipoyl Transacetylase (DLAT) Peptid
Kurzübersicht für Dihydrolipoyl Transacetylase (DLAT) Peptid (ABIN937613)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DVVSLATKAR EGKLQPHEFQ GGTFTISNLG MFGIKNFSAI INPPQACILA
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DLAT antibody,
Alternative Names: DLAT control peptide, DLAT antibody Blocking Peptide, Anti-DLAT Blocking Peptide, Dihydrolipoamide S-Acetyltransferase Blocking Peptide, DLTA Blocking Peptide, PDC-E2 Blocking Peptide, PDCE2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Hintergrund
- DLAT is dihydrolipoamide acetyltransferase, the E2 subunit of the mammalian pyruvate dehydrogenase complex of the inner mitochondrial membrane. Patients with primary biliary cirrhosis show autoantibodies to DLAT.
-
Molekulargewicht
- 69 kDa
Target
-